INR 545.15
(-1.37%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -200.6 Million INR | 59.62% |
2022 | 563.65 Million INR | -2876.81% |
2021 | 16.73 Billion INR | -101.92% |
2020 | 866.06 Million INR | -4.04% |
2019 | 456.49 Million INR | 200.94% |
2018 | 2.07 Billion INR | -198.33% |
2017 | 941.25 Million INR | -13.26% |
2016 | 1.16 Billion INR | -18.86% |
2015 | 1.81 Billion INR | 97.32% |
2014 | 723.6 Million INR | 190.45% |
2013 | 1.1 Billion INR | 28.41% |
2012 | -676.5 Million INR | -30.63% |
2011 | -774.8 Million INR | -125.85% |
2010 | 2.99 Billion INR | 36.24% |
2009 | 2.2 Billion INR | 791.29% |
2008 | 245.48 Million INR | -90.09% |
2007 | 2.49 Billion INR | -6.53% |
2006 | 2.67 Billion INR | 102.42% |
2005 | 1.31 Billion INR | 90.5% |
2004 | 692.52 Million INR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -139.9 Million INR | -199.2% |
2023 Q3 | 55.3 Million INR | 1775.76% |
2023 Q2 | -3.3 Million INR | 92.2% |
2023 Q1 | -42.3 Million INR | -170.42% |
2023 FY | - INR | 59.62% |
2023 Q4 | -60.4 Million INR | -209.22% |
2022 Q2 | 66.1 Million INR | 109.78% |
2022 FY | - INR | -2876.81% |
2022 Q4 | 60.07 Million INR | -72.51% |
2022 Q3 | 218.5 Million INR | 230.56% |
2022 Q1 | -676 Million INR | -104.1% |
2021 FY | - INR | -101.92% |
2021 Q3 | 135.2 Million INR | 67.95% |
2021 Q2 | 80.5 Million INR | 379.17% |
2021 Q1 | 16.8 Million INR | -69.35% |
2021 Q4 | 16.49 Billion INR | 12097.17% |
2020 Q4 | 54.82 Million INR | -67.73% |
2020 FY | - INR | -4.04% |
2020 Q1 | 237.9 Million INR | 1.46% |
2020 Q2 | 400.8 Million INR | 68.47% |
2020 Q3 | 169.9 Million INR | -57.61% |
2019 Q4 | 234.48 Million INR | -41.58% |
2019 Q2 | -25.1 Million INR | -108.81% |
2019 FY | - INR | 200.94% |
2019 Q3 | 401.4 Million INR | 1699.2% |
2019 Q1 | 284.8 Million INR | 142.9% |
2018 Q2 | -81.4 Million INR | 36.11% |
2018 FY | - INR | -198.33% |
2018 Q4 | -663.8 Million INR | -359.6% |
2018 Q3 | 255.7 Million INR | 414.13% |
2018 Q1 | -127.4 Million INR | 0.0% |
2017 FY | - INR | -13.26% |
2016 FY | - INR | -18.86% |
2015 FY | - INR | 97.32% |
2014 FY | - INR | 190.45% |
2013 FY | - INR | 28.41% |
2012 FY | - INR | -30.63% |
2011 FY | - INR | -125.85% |
2010 FY | - INR | 36.24% |
2009 FY | - INR | 791.29% |
2008 FY | - INR | -90.09% |
2007 FY | - INR | -6.53% |
2006 FY | - INR | 102.42% |
2005 FY | - INR | 90.5% |
2004 FY | - INR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Alfavision Overseas (India) Limited | 10.12 Million INR | 2081.43% |
Biocon Limited | 41.52 Billion INR | 100.483% |
Blue Jet Healthcare Limited | 2.29 Billion INR | 108.751% |
Concord Biotech Limited | 4.65 Billion INR | 104.306% |
Dishman Carbogen Amcis Limited | 3.07 Billion INR | 106.53% |
FERMENTA BIOTECH LIMITED | 262.68 Million INR | 176.366% |
GENOMIC VALLEY BIOTECH LIMITED | 147.4 Thousand INR | 136190.419% |
Lyka Labs Limited | 167.58 Million INR | 219.698% |
SAMSRITA LABS LIMITED | -2.46 Million INR | -8052.98% |
Servoteach Industries Limited | - INR | Infinity% |
SMS Lifesciences India Limited | 349.41 Million INR | 157.411% |
Supriya Lifescience Limited | 1.83 Billion INR | 110.927% |
Syngene International Limited | 10.84 Billion INR | 101.849% |
TAKE Solutions Limited | -1.05 Billion INR | 80.911% |
Titan Biotech Limited | 360.29 Million INR | 155.676% |
Transgene Biotek Limited | -4.33 Million INR | -4523.185% |
Vanta Bioscience Limited | 14.19 Million INR | 1513.572% |